These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. VEGF is associated with the poor survival of patients with prostate cancer: a meta-analysis. Zhan P; Ji YN; Yu LK Transl Androl Urol; 2013 Jun; 2(2):99-105. PubMed ID: 26816732 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of vascular endothelial growth factor A expression in gastric cancer: a meta-analysis. Ji YN; Wang Q; Li Y; Wang Z Tumour Biol; 2014 Mar; 35(3):2787-93. PubMed ID: 24234334 [TBL] [Abstract][Full Text] [Related]
6. VEGF-C expression is associated with the poor survival in gastric cancer tissue. Cao W; Fan R; Yang W; Wu Y Tumour Biol; 2014 Apr; 35(4):3377-83. PubMed ID: 24307624 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis. Yu XW; Wu TY; Yi X; Ren WP; Zhou ZB; Sun YQ; Zhang CQ Tumour Biol; 2014 Jan; 35(1):155-60. PubMed ID: 23907576 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of VEGF immunohistochemical expression in oral cancer: a meta-analysis of the literature. Zhao SF; Yang XD; Lu MX; Sun GW; Wang YX; Zhang YK; Pu YM; Tang EY Tumour Biol; 2013 Oct; 34(5):3165-71. PubMed ID: 23737289 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis. Zhan P; Ji YN Hepatobiliary Surg Nutr; 2014 Feb; 3(1):11-7. PubMed ID: 24696834 [TBL] [Abstract][Full Text] [Related]
10. TP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a meta-analysis. Zhan P; Ji YN; Yu LK Hepatobiliary Surg Nutr; 2013 Oct; 2(5):260-5. PubMed ID: 24570956 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of VEGF-C immunohistochemical expression in breast cancer: a meta-analysis. Gao S; Ma JJ; Lu C Tumour Biol; 2014 Feb; 35(2):1523-9. PubMed ID: 24078449 [TBL] [Abstract][Full Text] [Related]
12. TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis. Ji YN; Wang Q; Xue J Tumour Biol; 2014 Feb; 35(2):1653-9. PubMed ID: 24078450 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of VEGF in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Meta-Analysis. Cao G; Li X; Qin C; Li J Med Sci Monit; 2015 Oct; 21():3144-51. PubMed ID: 26476711 [TBL] [Abstract][Full Text] [Related]
14. Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature. Wang J; Guo Y; Wang B; Bi J; Li K; Liang X; Chu H; Jiang H Mol Biol Rep; 2012 Dec; 39(12):11153-65. PubMed ID: 23054001 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis. Zhan P; Wang J; Lv XJ; Wang Q; Qiu LX; Lin XQ; Yu LK; Song Y J Thorac Oncol; 2009 Sep; 4(9):1094-103. PubMed ID: 19687765 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of COX-2 immunohistochemical expression in colorectal cancer: a meta-analysis of the literature. Peng L; Zhou Y; Wang Y; Mou H; Zhao Q PLoS One; 2013; 8(3):e58891. PubMed ID: 23527044 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis. Zhang J; Zhang M; Ma H; Song X; He L; Ye X; Li X Medicine (Baltimore); 2018 Jun; 97(24):e11130. PubMed ID: 29901640 [TBL] [Abstract][Full Text] [Related]
18. Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma. Chen L; Shi Y; Jiang CY; Wei LX; Lv YL; Wang YL; Dai GH Int J Biol Markers; 2011; 26(2):108-16. PubMed ID: 21574155 [TBL] [Abstract][Full Text] [Related]
19. Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis. Schoenleber SJ; Kurtz DM; Talwalkar JA; Roberts LR; Gores GJ Br J Cancer; 2009 May; 100(9):1385-92. PubMed ID: 19401698 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of FoxM1 expression in non-small cell lung cancer. Sun Q; Dong M; Chen Y; Zhang J; Qiao J; Guo X J Thorac Dis; 2016 Jun; 8(6):1269-73. PubMed ID: 27293846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]